Special Diabetes Program: Funding Opportunities

Below are current funding opportunities supported by the Special Diabetes Program. For other NIH funding opportunities, please see the NIH Guide for Grants and Contracts.

View archived research funding opportunities.

Posted Date Title Open Date (Earliest Submission Date) Application Due Date Full Announcement
7/14/2021 Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed) September 20, 2021 October 20, 2021 RFA-DK-21-013
6/25/2021  Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) January 17, 2022 February 17, 2022 and October 7, 2022 RFA-DK-21-021
6/3/2021  Characterization of Islet-derived Extracellular Vesicles for Improved Detection, Monitoring, Classification, and Treatment of Type 1 Diabetes (R01 Clinical Trial Not Allowed)  October 3, 2021  November 3, 2021 RFA-DK-21-016
5/19/2021  Support for Small Business Innovation Research (SBIR) Development and Testing  of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) February 9, 2022  March 9, 2022 and October 7, 2022 RFA-DK-21-012
5/7/2021  Standardization of C-peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed) September 20, 2021 October 20, 2021 RFA-DK-21-007
5/6/2021  Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed) February 9, 2022  March 9 and October 7, 2022  RFA-DK-21-011
4/6/2021  Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) September 20, 2021 October 20, 2021 RFA-DK-21-006
4/5/2021  Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional) July 17, 2021 August 17, 2021 RFA-DK-21-501
3/17/2021 The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) May 22, 2021 June 22, 2021 and March 9, 2022 RFA-DK-21-004
1/13/2021 Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed) March 22, 2021 April 22 and November 3, 2021 RFA-DK-21-001
1/6/2021 Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01-Clinical Trial Optional) February 15, 2021 March 15 and October 15, 2021 RFA-HL-21-014
1/3/2014 Diabetic Complications Consortium Preclinical Testing Program Ongoing Not Applicable DCC-PTP Website